Fyn: a novel molecular target in cancer
- PMID: 20151426
- PMCID: PMC2847065
- DOI: 10.1002/cncr.24879
Fyn: a novel molecular target in cancer
Abstract
Fyn is 59-kDa member of the Src family of kinases that is historically associated with T-cell and neuronal signaling in development and normal cellular physiology. Whereas Src has been heavily studied in cancer, less attention has been traditionally awarded to the other Src kinases such as Fyn. Our group has shown that Fyn is particularly upregulated in prostate cancer in contrast to the alternative members of the Src family. This suggests that it may mediate several important processes attributed to Src kinases in prostate cancer and other malignancies. These functions include not only cellular growth and proliferation but also morphogenesis and cellular motility. Together, these suggest a role for Fyn in both progression and metastasis. As several agents in clinical development affect Fyn activation, understanding the role that Fyn plays in cancer is of great importance in oncology. Cancer 2010. (c) 2010 American Cancer Society.
Figures
Similar articles
-
FYN: emerging biological roles and potential therapeutic targets in cancer.J Transl Med. 2023 Feb 5;21(1):84. doi: 10.1186/s12967-023-03930-0. J Transl Med. 2023. PMID: 36740671 Free PMC article. Review.
-
Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.Carcinogenesis. 2012 May;33(5):969-75. doi: 10.1093/carcin/bgs109. Epub 2012 Feb 21. Carcinogenesis. 2012. PMID: 22354875
-
Distinct roles for N-Cadherin linked c-Src and fyn kinases in lens development.Dev Dyn. 2013 May;242(5):469-84. doi: 10.1002/dvdy.23935. Epub 2013 Mar 12. Dev Dyn. 2013. PMID: 23361870 Free PMC article.
-
Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells.Clin Cancer Res. 2011 May 15;17(10):3112-22. doi: 10.1158/1078-0432.CCR-10-1264. Epub 2011 Mar 1. Clin Cancer Res. 2011. PMID: 21364031 Free PMC article.
-
The Src family kinases: distinct functions of c-Src, Yes, and Fyn in the liver.Biomol Concepts. 2013 Apr;4(2):129-42. doi: 10.1515/bmc-2012-0047. Biomol Concepts. 2013. PMID: 25436571 Review.
Cited by
-
Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase.Mol Med. 2012 Jul 18;18(1):834-42. doi: 10.2119/molmed.2012.00029. Mol Med. 2012. PMID: 22481272 Free PMC article. Review.
-
A Pyrazolo[3,4-d]pyrimidine compound inhibits Fyn phosphorylation and induces apoptosis in natural killer cell leukemia.Oncotarget. 2016 Oct 4;7(40):65171-65184. doi: 10.18632/oncotarget.11496. Oncotarget. 2016. PMID: 27566560 Free PMC article.
-
Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma.Onco Targets Ther. 2020 Aug 14;13:8125-8140. doi: 10.2147/OTT.S263047. eCollection 2020. Onco Targets Ther. 2020. PMID: 32884295 Free PMC article.
-
FYN: emerging biological roles and potential therapeutic targets in cancer.J Transl Med. 2023 Feb 5;21(1):84. doi: 10.1186/s12967-023-03930-0. J Transl Med. 2023. PMID: 36740671 Free PMC article. Review.
-
Role of Sphingosylphosphorylcholine in Tumor and Tumor Microenvironment.Cancers (Basel). 2019 Oct 31;11(11):1696. doi: 10.3390/cancers11111696. Cancers (Basel). 2019. PMID: 31683697 Free PMC article. Review.
References
-
- Jemal A, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66. - PubMed
-
- Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene. 2004;23(48):7918–27. - PubMed
-
- Vlahovic G, Crawford J. Activation of tyrosine kinases in cancer. Oncologist. 2003;8(6):531–8. - PubMed
-
- Yeatman TJ. A renaissance for SRC. Nat Rev Cancer. 2004;4(6):470–80. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous